TABLE OF CONTENTS

1 INTRODUCTION 16
1.1 OBJECTIVES OF THE STUDY 16
1.2 MARKET DEFINITION 16
1.3 MARKET SCOPE 16
1.3.1 MARKETS COVERED 17
1.3.2 YEARS CONSIDERED FOR THE STUDY 18
1.4 CURRENCY 18
1.5 STAKEHOLDERS 18
2 RESEARCH METHODOLOGY 19
2.1 RESEARCH DATA 19
2.1.1 SECONDARY DATA 21
2.1.1.1 Key data from secondary sources 21
2.1.2 PRIMARY DATA 23
2.1.2.1 Key data from primary sources 23
2.1.2.2 Breakdown of primaries 24
2.2 MARKET SIZE ESTIMATION 24
2.2.1 PRODUCT-BASED MARKET ESTIMATION 24
2.2.2 VOLUME-BASED MARKET ESTIMATION 26
2.2.3 PRIMARY RESEARCH VALIDATION 28
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 29
2.4 RESEARCH LIMITATIONS AND ASSUMPTIONS 30
2.4.1 LIMITATIONS 30
2.4.2 ASSUMPTIONS 30
3 EXECUTIVE SUMMARY 31
4 PREMIUM INSIGHTS 36
4.1 PARTICLE THERAPY: MARKET OVERVIEW 36
4.2 REGIONAL ANALYSIS: PARTICLE THERAPY MARKET, BY PRODUCT & SERVICE 37
4.3 PARTICLE THERAPY MARKET SIZE, BY TYPE 37
4.4 PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE 38
4.5 REGIONAL ANALYSIS: PARTICLE THERAPY MARKET, BY APPLICATION 39
4.6 PARTICLE THERAPY MARKET, BY REGION 40
 
5 MARKET OVERVIEW 41
5.1 INTRODUCTION 41
5.2 MARKET DYNAMICS 41
5.2.1 DRIVERS 42
5.2.1.1 Advantages offered by particle therapy over photon therapy 42
5.2.1.2 Growing global prevalence of cancer 42
5.2.1.3 Growing adoption of particle therapy in clinical trials 43
5.2.1.4 Increasing number of particle therapy centers worldwide 44
5.2.2 RESTRAINTS 44
5.2.2.1 Infrastructural challenges in healthcare facilities 44
5.2.2.2 Affordability and accessibility of treatments 45
5.2.2.3 Unfavorable reimbursement policies and limited insurance coverage for particle therapy 45
5.2.3 OPPORTUNITIES 46
5.2.3.1 Emerging markets 46
5.2.4 INDUSTRY TRENDS 47
5.2.4.1 GROWING ADOPTION OF PENCIL-BEAM SCANNING 47
6 PARTICLE THERAPY MARKET, BY TYPE 48
6.1 INTRODUCTION 49
6.2 PROTON THERAPY 50
6.2.1 PROTON THERAPY IS INCREASINGLY BEING ADOPTED AS A PRIMARY TREATMENT MODE FOR VARIOUS CANCER TYPES 50
6.3 HEAVY ION THERAPY 51
6.3.1 THE USE OF HEAVY ION THERAPY IS STILL IN THE EXPERIMENTAL PHASE ACROSS MANY REGIONS 51
7 PARTICLE THERAPY MARKET, BY PRODUCT & SERVICE 52
7.1 INTRODUCTION 53
7.2 PRODUCTS 54
7.2.1 CYCLOTRONS 56
7.2.1.1 Leading players in the particle therapy market mainly manufacture cyclotrons 56
7.2.2 SYNCHROTRONS 57
7.2.2.1 Increasing investments into the development of synchrotron facilities are contributing to market growth 57
7.2.3 SYNCHROCYCLOTRONS 58
7.2.3.1 The high space requirements of synchrocyclotrons are limiting their widespread adoption 58
7.3 SERVICES 59
 
8 PARTICLE THERAPY MARKET, BY SYSTEM 60
8.1 INTRODUCTION 61
8.2 MULTI-ROOM SYSTEMS 62
8.2.1 LOWER SHIELDING REQUIREMENTS AND FASTER BEAM-SWITCHING CAPABILITIES OF MULTI-ROOM SYSTEMS ARE INCREASING INTEREST AMONG END USERS 62
8.3 SINGLE-ROOM SYSTEMS 63
8.3.1 COMPACT STRUCTURE AND REDUCED CAPITAL COSTS ARE LEADING TO HIGH GROWTH OF SINGLE-ROOM SYSTEMS 63
9 PARTICLE THERAPY MARKET, BY CANCER TYPE 64
9.1 INTRODUCTION 65
9.1.1 PEDIATRIC CANCER 66
9.1.1.1 BETTER CONTROL OF RADIATION WITH PARTICLE THERAPY MAKES IT THE MOST SUITABLE TREATMENT MODE FOR PEDIATRIC CANCER 66
9.1.2 PROSTATE CANCER 66
9.1.2.1 PARTICLE THERAPY OFFERS A MINIMALLY INVASIVE ALTERNATIVE WITH INCREASED ACCURACY FOR PROSTATE CANCER TREATMENT 66
9.1.3 LUNG CANCER 67
9.1.3.1 RISING NUMBER OF CLINICAL TRIALS TO OPTIMIZE THE USE OF PARTICLE THERAPY FOR LUNG CANCER IS DRIVING THE GROWTH OF THE MARKET 67
9.1.4 BREAST CANCER 67
9.1.4.1 LIMITED RADIATION EXPOSURE WITH REDUCED SIDE-EFFECTS IS INCREASING THE ADOPTION OF PARTICLE THERAPY FOR BREAST CANCER 67
9.1.5 HEAD AND NECK CANCER 67
9.1.5.1 THE USE OF PENCIL-BEAM SCANNING FOR PROTON THERAPY SUPPORTS MARKET GROWTH FOR THIS SEGMENT 67
9.1.6 OTHER CANCERS 68
10 PARTICLE THERAPY MARKET, BY APPLICATION 69
10.1 INTRODUCTION 70
10.2 TREATMENT APPLICATIONS 71
10.2.1 INTRODUCTION OF SMALL FOOTPRINT SINGLE-ROOM PARTICLE THERAPY CENTRES IS PROMOTING THE ADOPTION OF PARTICLE THERAPY FOR CANCER TREATMENT 71
10.3 RESEARCH APPLICATIONS 72
10.3.1 INCREASING AVAILABILITY OF FUNDING FOR PARTICLE THERAPY-RELATED RESEARCH PROJECTS IS PROVIDING GROWTH OPPORTUNITIES IN RESEARCH APPLICATIONS 72
 
11 PARTICLE THERAPY MARKET, BY REGION 74
11.1 INTRODUCTION 75
11.2 NORTH AMERICA 77
11.2.1 US 80
11.2.1.1 Growing number of particle therapy centers in the US to drive market growth 80
11.2.2 CANADA 82
11.2.2.1 Canadian government undertaking initiatives to include particle therapy as a treatment method 82
11.3 EUROPE 83
11.3.1 FRANCE 87
11.3.1.1 Increasing healthcare expenditure in France is supporting the adoption of particle therapy products 87
11.3.2 GERMANY 88
11.3.2.1 Increasing research in the field of proton & heavy ion therapy to drive the growth of the particle therapy market in Germany 88
11.3.3 UK 90
11.3.3.1 Cyclotrons segment dominated the particle therapy market in the UK 90
11.3.4 REST OF EUROPE 91
11.4 ASIA PACIFIC 93
11.4.1 JAPAN 97
11.4.1.1 Japan is the largest user of heavy ion therapy for the treatment of various types of cancers 97
11.4.2 CHINA 99
11.4.2.1 Growing interest of major market players to increase their presence in China will drive the growth of the particle therapy market in the country 99
11.4.3 INDIA 101
11.4.3.1 Leading product manufacturers are entering the Indian particle therapy market owing to the high growth opportunities in the country 101
11.4.4 REST OF ASIA PACIFIC 102
11.5 REST OF THE WORLD 104
11.5.1 INADEQUATE HEALTHCARE INFRASTRUCTURE IS RESTRAINING THE WIDESPREAD ADOPTION OF PARTICLE THERAPY IN THE REGION 104
12 COMPETITIVE LANDSCAPE 108
12.1 INTRODUCTION 108
12.2 MARKET SHARE ANALYSIS 109
12.3 COMPETITIVE SCENARIO 110
12.3.1 PRODUCT LAUNCHES AND APPROVALS 110
12.3.2 ACQUISITIONS 110
12.3.3 EXPANSIONS 111
12.3.4 AGREEMENTS AND COLLABORATIONS 111
 
13 COMPANY PROFILES: PARTICLE THERAPY MARKET 112
(Business Overview, Products Offered, Recent Developments, MnM View)*
13.1 VARIAN MEDICAL SYSTEMS, INC. 112
13.2 ION BEAM APPLICATIONS SA (IBA) 115
13.3 MEVION MEDICAL SYSTEMS, INC. 118
13.4 PROVISION HEALTHCARE, LLC 120
13.5 SUMITOMO HEAVY INDUSTRIES, LTD. 122
13.6 HITACHI, LTD. 124
13.7 OPTIVUS PROTON THERAPY, INC. 126
13.8 PROTOM INTERNATIONAL, INC. 127
13.9 ADVANCED ONCOTHERAPY PLC. 128
13.10 DANFYSIK A/S 130
*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.
14 APPENDIX 131
14.1 DISCUSSION GUIDE 131
14.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 135
14.3 AVAILABLE CUSTOMIZATIONS 137
14.4 RELATED REPORTS 137
14.5 AUTHOR DETAILS 138

LIST OF TABLES

TABLE 1 PARTICLE THERAPY MARKET, BY TYPE, 2016–2023 (USD MILLION) 49
TABLE 2 PROTON THERAPY MARKET, BY REGION, 2016–2023 (USD MILLION) 50
TABLE 3 HEAVY ION THERAPY MARKET, BY REGION, 2016–2023 (USD MILLION) 51
TABLE 4 PARTICLE THERAPY MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 53
TABLE 5 PARTICLE THERAPY PRODUCT & SERVICE MARKET, BY REGION,
2016–2023 (USD MILLION) 53
TABLE 6 PARTICLE THERAPY PRODUCTS MARKET, BY TYPE, 2016–2023 (USD MILLION) 55
TABLE 7 PARTICLE THERAPY PRODUCTS MARKET, BY TYPE, 2016–2023 (UNITS) 55
TABLE 8 PARTICLE THERAPY PRODUCTS MARKET, BY REGION, 2016–2023 (USD MILLION) 55
TABLE 9 CYCLOTRONS MARKET, BY REGION, 2016–2023 (USD MILLION) 56
TABLE 10 CYCLOTRONS MARKET, BY REGION, 2016–2023 (UNITS) 57
TABLE 11 SYNCHROTRONS MARKET, BY REGION, 2016–2023 (USD MILLION) 57
TABLE 12 SYNCHROTRONS MARKET, BY REGION, 2016–2023 (UNITS) 58
TABLE 13 SYNCHROCYCLOTRONS MARKET, BY REGION, 2016–2023 (USD MILLION) 58
TABLE 14 SYNCHROCYCLOTRONS MARKET, BY REGION, 2016–2023 (UNITS) 59
TABLE 15 PARTICLE THERAPY SERVICES MARKET, BY REGION, 2016–2023 (USD MILLION) 59
TABLE 16 PARTICLE THERAPY MARKET, BY SYSTEM, 2016–2023 (USD MILLION) 61
TABLE 17 PARTICLE THERAPY MARKET FOR MULTI-ROOM SYSTEMS, BY REGION,
2016–2023 (USD MILLION) 62
TABLE 18 PARTICLE THERAPY MARKET FOR SINGLE-ROOM SYSTEMS, BY REGION,
2016–2023 (USD MILLION) 63
TABLE 19 PARTICLE THERAPY MARKET, BY CANCER TYPE, 2016–2023 (USD MILLION) 65
TABLE 20 PARTICLE THERAPY MARKET, BY APPLICATION, 2016–2023 (USD MILLION) 70
TABLE 21 PARTICLE THERAPY MARKET FOR TREATMENT APPLICATIONS, BY REGION,
2016–2023 (USD MILLION) 72
TABLE 22 PARTICLE THERAPY MARKET FOR RESEARCH APPLICATIONS, BY REGION,
2016–2023 (USD MILLION) 73
TABLE 23 PARTICLE THERAPY MARKET, BY REGION, 2016–2023 (USD MILLION) 76
TABLE 24 NORTH AMERICA: PARTICLE THERAPY MARKET, BY COUNTRY,
2016–2018 (USD MILLION) 78
TABLE 25 NORTH AMERICA: PARTICLE THERAPY MARKET, BY TYPE,
2016–2023 (USD MILLION) 78
TABLE 26 NORTH AMERICA: PARTICLE THERAPY MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 78
TABLE 27 NORTH AMERICA: PARTICLE THERAPY PRODUCTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 79
TABLE 28 NORTH AMERICA: PARTICLE THERAPY PRODUCTS MARKET, BY TYPE,
2016–2023 (UNITS) 79
TABLE 29 NORTH AMERICA: PARTICLE THERAPY MARKET, BY SYSTEM,
2016–2023 (USD MILLION) 79
TABLE 30 NORTH AMERICA: PARTICLE THERAPY MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 80
TABLE 31 US: PARTICLE THERAPY MARKET, BY PRODUCT & SERVICE,
2016–2018 (USD MILLION) 81
TABLE 32 US: PARTICLE THERAPY PRODUCTS MARKET, BY TYPE, 2016–2018 (USD MILLION) 81
TABLE 33 US: PARTICLE THERAPY PRODUCTS MARKET, BY TYPE, 2016–2018 (UNITS) 81
TABLE 34 CANADA: PARTICLE THERAPY MARKET, BY PRODUCT & SERVICE,
2016–2018 (USD MILLION) 82
TABLE 35 CANADA: PARTICLE THERAPY PRODUCTS MARKET, BY TYPE,
2016–2018 (USD MILLION) 82
TABLE 36 CANADA: PARTICLE THERAPY PRODUCTS MARKET, BY TYPE, 2016–2018 (UNITS) 83
TABLE 37 EUROPE: PARTICLE THERAPY MARKET, BY COUNTRY, 2016–2018 (USD MILLION) 85
TABLE 38 EUROPE: PARTICLE THERAPY MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 85
TABLE 39 EUROPE: PARTICLE THERAPY PRODUCTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 85
TABLE 40 EUROPE: PARTICLE THERAPY PRODUCTS MARKET, BY TYPE, 2016–2023 (UNITS) 86
TABLE 41 EUROPE: PARTICLE THERAPY MARKET, BY TYPE, 2016–2023 (USD MILLION) 86
TABLE 42 EUROPE: PARTICLE THERAPY MARKET, BY SYSTEM, 2016–2023 (USD MILLION) 86
TABLE 43 EUROPE: PARTICLE THERAPY MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 87
TABLE 44 FRANCE: PARTICLE THERAPY MARKET, BY PRODUCT & SERVICE,
2016–2018 (USD MILLION) 87
TABLE 45 FRANCE: PARTICLE THERAPY PRODUCTS MARKET, BY TYPE,
2016–2018 (USD MILLION) 88
TABLE 46 FRANCE: PARTICLE THERAPY PRODUCTS MARKET, BY TYPE, 2016–2018 (UNITS) 88
TABLE 47 GERMANY: PARTICLE THERAPY MARKET, BY PRODUCT & SERVICE,
2016–2018 (USD MILLION) 89
TABLE 48 GERMANY: PARTICLE THERAPY PRODUCTS MARKET, BY TYPE,
2016–2018 (USD MILLION) 89
TABLE 49 GERMANY: PARTICLE THERAPY PRODUCTS MARKET, BY TYPE, 2016–2018 (UNITS) 89
TABLE 50 UK: PARTICLE THERAPY MARKET, BY PRODUCT & SERVICE,
2016–2018 (USD MILLION) 90
TABLE 51 UK: PARTICLE THERAPY PRODUCTS MARKET, BY TYPE, 2016–2018 (USD MILLION) 91
TABLE 52 UK: PARTICLE THERAPY PRODUCTS MARKET, BY TYPE, 2016–2018 (UNITS) 91
TABLE 53 ROE: PARTICLE THERAPY MARKET, BY PRODUCT & SERVICE,
2016–2018 (USD MILLION) 92
TABLE 54 ROE: PARTICLE THERAPY PRODUCTS MARKET, BY TYPE,
2016–2018 (USD MILLION) 92
TABLE 55 ROE: PARTICLE THERAPY PRODUCTS MARKET, BY TYPE, 2016–2018 (UNITS) 92
TABLE 56 ASIA PACIFIC: PARTICLE THERAPY MARKET, BY COUNTRY,
2016–2018 (USD MILLION) 95
TABLE 57 ASIA PACIFIC: PARTICLE THERAPY MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 95
TABLE 58 ASIA PACIFIC: PARTICLE THERAPY MARKET, BY TYPE, 2016–2023 (USD MILLION) 95
TABLE 59 ASIA PACIFIC: PARTICLE THERAPY PRODUCTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 96
TABLE 60 ASIA PACIFIC: PARTICLE THERAPY PRODUCTS MARKET, BY TYPE,
2016–2023 (UNITS) 96
TABLE 61 ASIA PACIFIC: PARTICLE THERAPY MARKET, BY SYSTEM,
2016–2023 (USD MILLION) 97
TABLE 62 ASIA PACIFIC: PARTICLE THERAPY MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 97
TABLE 63 JAPAN: PARTICLE THERAPY MARKET, BY PRODUCT & SERVICE,
2016–2018 (USD MILLION) 98
TABLE 64 JAPAN: PARTICLE THERAPY PRODUCTS MARKET, BY TYPE,
2016–2018 (USD MILLION) 98
TABLE 65 JAPAN: PARTICLE THERAPY PRODUCTS MARKET, BY TYPE, 2016–2018 (UNITS) 99
TABLE 66 CHINA: PARTICLE THERAPY MARKET, BY PRODUCT & SERVICE,
2016–2018 (USD MILLION) 100
TABLE 67 CHINA: PARTICLE THERAPY PRODUCTS MARKET, BY TYPE,
2016–2018 (USD MILLION) 100
TABLE 68 CHINA: PARTICLE THERAPY PRODUCTS MARKET, BY TYPE, 2016–2018 (UNITS) 100
TABLE 69 INDIA: PARTICLE THERAPY MARKET, BY PRODUCT & SERVICE,
2016–2018 (USD MILLION) 101
TABLE 70 INDIA: PARTICLE THERAPY PRODUCTS MARKET, BY TYPE,
2016–2018 (USD MILLION) 101
TABLE 71 INDIA: PARTICLE THERAPY PRODUCTS MARKET, BY TYPE, 2016–2018 (UNITS) 102
TABLE 72 ROAPAC: PARTICLE THERAPY MARKET, BY PRODUCT & SERVICE,
2016–2018 (USD MILLION) 103
TABLE 73 ROAPAC: PARTICLE THERAPY PRODUCTS MARKET, BY TYPE,
2016–2018 (USD MILLION) 103
TABLE 74 ROAPAC: PARTICLE THERAPY PRODUCTS MARKET, BY TYPE, 2016–2018 (UNITS) 103
TABLE 75 ROW: PARTICLE THERAPY MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 106
TABLE 76 ROW: PARTICLE THERAPY MARKET, BY TYPE, 2016–2023 (USD MILLION) 106
TABLE 77 ROW: PARTICLE THERAPY PRODUCTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 106
TABLE 78 ROW: PARTICLE THERAPY PRODUCTS MARKET, BY TYPE, 2016–2023 (UNITS) 107
TABLE 79 ROW: PARTICLE THERAPY MARKET, BY SYSTEM, 2016–2023 (USD MILLION) 107
TABLE 80 ROW: PARTICLE THERAPY MARKET, BY APPLICATION, 2016–2023 (USD MILLION) 107


LIST OF FIGURES

FIGURE 1 PARTICLE THERAPY MARKET: RESEARCH METHODOLOGY STEPS 19
FIGURE 2 RESEARCH DESIGN 20
FIGURE 3 BOTTOM-UP APPROACH MARKET SIZE ESTIMATION: PARTICLE THERAPY MARKET 25
FIGURE 4 TOP-DOWN APPROACH MARKET SIZE ESTIMATION: PARTICLE
THERAPY PRODUCT MARKET 26
FIGURE 5 TOP-DOWN APPROACH MARKET SIZE ESTIMATION: PARTICLE
THERAPY SERVICES MARKET 27
FIGURE 6 DATA TRIANGULATION METHODOLOGY 29
FIGURE 7 PARTICLE THERAPY MARKET, BY TYPE, 2018 VS. 2023 (USD MILLION) 31
FIGURE 8 PARTICLE THERAPY PRODUCTS MARKET SHARE, BY TYPE, 2018 VS. 2023 32
FIGURE 9 REGIONAL ANALYSIS: PARTICLE THERAPY MARKET, BY SYSTEM,
2018 (USD MILLION) 33
FIGURE 10 PARTICLE THERAPY MARKET SHARE, BY CANCER TYPE, 2018 VS. 2023 34
FIGURE 11 PARTICLE THERAPY MARKET, BY APPLICATION, 2018 VS. 2023 (USD MILLION) 34
FIGURE 12 PARTICLE THERAPY MARKET: GEOGRAPHICAL SNAPSHOT 35
FIGURE 13 INCREASING CANCER PREVALENCE IS DRIVING GROWTH OF THE PARTICLE THERAPY MARKET 36
FIGURE 14 SERVICES SEGMENT TO WITNESS HIGH GROWTH IN THE APAC MARKET DURING THE FORECAST PERIOD 37
FIGURE 15 PROTON THERAPY WILL DOMINATE THE MARKET DURING THE FORECAST PERIOD (2018–2023) 37
FIGURE 16 PEDIATRIC CANCER SEGMENT WILL GROW AT THE FASTEST RATE IN THE MARKET DURING THE FORECAST PERIOD 38
FIGURE 17 TREATMENT APPLICATION SEGMENT IS ESTIMATED TO HOLD THE LARGEST SHARE OF THE MARKET GLOBALLY IN 2018 39
FIGURE 18 ASIA PACIFIC TO WITNESS FASTEST GROWTH DURING THE FORECAST PERIOD (2018–2023) 40
FIGURE 20 GROWING INCIDENCE OF CANCER, BY REGION, 2012–2020 (THOUSANDS) 43
FIGURE 21 PROTON THERAPY SEGMENT TO DOMINATE THE PARTICLE THERAPY MARKET DURING THE FORECAST PERIOD 49
FIGURE 22 CYCLOTRONS SEGMENT TO DOMINATE THE PARTICLE THERAPY PRODUCTS MARKET 54
FIGURE 23 MULTI-ROOM SYSTEMS SEGMENT TO DOMINATE THE PARTICLE THERAPY MARKET DURING THE FORECAST PERIOD 61
FIGURE 24 PEDIATRIC CANCER SEGMENT TO WITNESS HIGHEST GROWTH IN THE PARTICLE THERAPY MARKET DURING THE FORECAST PERIOD 65
FIGURE 25 TREATMENT APPLICATIONS TO DOMINATE THE PARTICLE THERAPY MARKET DURING THE FORECAST PERIOD 70
FIGURE 26 ASIA PACIFIC TO REGISTER THE HIGHEST GROWTH IN THE PARTICLE THERAPY MARKET DURING THE FORECAST PERIOD 75
FIGURE 27 NUMBER OF PARTICLE THERAPY FACILITIES PRESENT (AS OF OCTOBER 2018) & UNDER CONSTRUCTION ACROSS THE GLOBE 76
FIGURE 28 NORTH AMERICA: PARTICLE THERAPY MARKET SNAPSHOT 77
FIGURE 29 EUROPE: PARTICLE THERAPY MARKET SNAPSHOT 84
FIGURE 30 ASIA PACIFIC: PARTICLE THERAPY MARKET SNAPSHOT 94
FIGURE 31 ROW: PARTICLE THERAPY MARKET SNAPSHOT 105
FIGURE 32 KEY DEVELOPMENTS BY LEADING MARKET PLAYERS IN THE PARTICLE THERAPY MARKET, 2015–2018 108
FIGURE 33 PARTICLE THERAPY MARKET SHARE, BY KEY PLAYER, 2017 109
FIGURE 34 VARIAN MEDICAL SYSTEMS, INC.: COMPANY SNAPSHOT 112
FIGURE 35 ION BEAM APPLICATIONS SA: COMPANY SNAPSHOT 115
FIGURE 36 SUMITOMO HEAVY INDUSTRIES: COMPANY SNAPSHOT 122
FIGURE 37 HITACHI, LTD.: COMPANY SNAPSHOT 124